bovnews3h
Akebia Therapeutics Inc (AKBA) Stock Settles at $2.39: What’s Contributing to This Price Point?
Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $2.39 which represents a slight increase of $0.02 or 0.84% from the prior close of $2.37. The stock opened at $2.4 and ...
bovnews5h
What’s Causing Ginkgo Bioworks Holdings Inc (DNA) Stock’s 12.72% Jump Over the Last Six Months?
Ginkgo Bioworks Holdings Inc (DNA) stock saw a modest uptick, ending the day at $12.9 which represents a slight increase of $1.32 or 11.40% from the prior close of $11.58. The stock opened at $11.65 ...
D.R. Horton price target lowered to $171 from $186 at BTIG
BTIG lowered the firm’s price target on D.R. Horton (DHI) to $171 from $186 and keeps a Buy rating on the shares. The company ...
SL Green Realty price target raised to $75 from $60 at BTIG
BTIG raised the firm’s price target on SL Green Realty (SLG) to $75 from $60 and keeps a Buy rating on the shares. The firm ...
BTIG Sticks to Their Hold Rating for Palo Alto Networks (PANW)
In a report released yesterday, Gray Powell from BTIG maintained a Hold rating on Palo Alto Networks (PANW – Research Report). The company’s ...
Promising Clinical Developments and Strategic Initiatives Drive Buy Rating for Viking Therapeutics
BTIG analyst Justin Zelin reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) yesterday and set a price target of ...
Ameritas Advisory Services LLC Buys New Stake in Okta, Inc. (NASDAQ:OKTA)
Ameritas Advisory Services LLC purchased a new position in shares of Okta, Inc. (NASDAQ:OKTA – Free Report) in the fourth ...
BTIG cuts Outset Medical target to $3, maintains Buy rating
BTIG analyst Maria Thibault revised the price target for Outset Medical (TASE:PMCN) Inc. (NASDAQ:OM) to $3.00, a decrease ...
Hosted on MSN22h
Common App app data concerning for Flywire, says BTIG
BTIG analyst Andrew Harte says annual data published by The Common App showed first-year undergraduate applications from international students ...